Blog
Feedback
schliessen

Filtern

 

Bibliotheken

Logo der Bibliothek

Logo FID Pharmazie PubPharm Discovery System Universitätsbibliothek Braunschweig Institut für Informationssysteme

Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia : case series

Year of Publication: 2020
Contained in: Annals of the rheumatic diseases Vol. 79, No. 10 (2020), p. 1381-1382
All journal articles: Search for all articles in this journal
Language: English
Contributors: Aouba, Achille | Author
Baldolli, Aurelie
Geffray, Loïk
Verdon, Renaud
Bergot, Emmanuel
Martin-Silva, Nicolas
Justet, Aurélien
Full text access:
Electronic availability is being checked...
Links: Full Text (dx.doi.org)
Keywords: 4QWG6N8QKH
83905-01-5
9007-41-4
Letter
antirheumatic agents
biological therapy
cytokines
interleukin 1 receptor antagonist protein
therapeutics
Additional Keywords: Aged, 80 and over
Anti-Bacterial Agents
Azithromycin
Betacoronavirus
C-Reactive Protein
Coronavirus Infections
Disease Progression
Enzyme Inhibitors
Female
Hospitalization
Humans
Hydroxychloroquine
Intensive Care Units
Interleukin 1 Receptor Antagonist Protein
Lung
Male
Middle Aged
Pandemics
Pneumonia, Viral
Respiratory Distress Syndrome, Adult
Severity of Illness Index
Tomography, X-Ray Computed
Treatment Outcome
ISSN: 1468-2060
Note: Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Notes: Date Completed 24.09.2020
Date Revised 24.09.2020
published: Print-Electronic
Citation Status MEDLINE
Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
PMID:
    32376597
Physical Description: Online-Ressource
ID (e.g. DOI, URN): 10.1136/annrheumdis-2020-217706
more publication details ...

Associated Publications

  • Associated records are being queried...
more (+)
Internes Format
LEADER 03938nma a2201045 c 4500
001 NLM310463343
003 DE-601
005 20200925213834.0
007 cr uuu---uuuuu
008 200507s2020 000 0 eng d
024 7 |a 10.1136/annrheumdis-2020-217706  |2 doi 
028 5 2 |a pubmed20n1351.xml 
035 |a (DE-599)NLM32376597 
040 |b ger  |c GBVCP 
041 0 |a eng 
100 1 |a Aouba, Achille 
245 1 0 |a Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia  |h Elektronische Ressource  |b case series 
300 |a Online-Ressource 
500 |a Date Completed 24.09.2020 
500 |a Date Revised 24.09.2020 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
500 |a Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine 
611 2 7 |a Letter  |2 gnd 
653 2 |a Aged, 80 and over  |6 D000369 
653 2 |a Anti-Bacterial Agents  |6 D000900  |a therapeutic use  |6 Q000627 
653 2 |a Azithromycin  |6 D017963  |a therapeutic use  |6 Q000627 
653 2 |a Betacoronavirus  |6 D000073640 
653 2 |a C-Reactive Protein  |6 D002097  |a immunology  |6 Q000276 
653 2 |a Coronavirus Infections  |6 D018352  |a diagnostic imaging  |6 Q000000981  |a *drug therapy  |6 Q000188  |a immunology  |6 Q000276  |a physiopathology  |6 Q000503 
653 2 |a Disease Progression  |6 D018450 
653 2 |a Enzyme Inhibitors  |6 D004791  |a therapeutic use  |6 Q000627 
653 2 |a Female  |6 D005260 
653 2 |a Hospitalization  |6 D006760 
653 2 |a Humans  |6 D006801 
653 2 |a Hydroxychloroquine  |6 D006886  |a therapeutic use  |6 Q000627 
653 2 |a Intensive Care Units  |6 D007362 
653 2 |a Interleukin 1 Receptor Antagonist Protein  |6 D053590  |a *therapeutic use  |6 Q000627 
653 2 |a Lung  |6 D008168  |a diagnostic imaging  |6 Q000000981 
653 2 |a Male  |6 D008297 
653 2 |a Middle Aged  |6 D008875 
653 2 |a Pandemics  |6 D058873 
653 2 |a Pneumonia, Viral  |6 D011024  |a diagnostic imaging  |6 Q000000981  |a *drug therapy  |6 Q000188  |a immunology  |6 Q000276  |a physiopathology  |6 Q000503 
653 2 |a Respiratory Distress Syndrome, Adult  |6 D012128  |a physiopathology  |6 Q000503 
653 2 |a Severity of Illness Index  |6 D012720 
653 2 |a Tomography, X-Ray Computed  |6 D014057 
653 2 |a Treatment Outcome  |6 D016896 
655 7 |a antirheumatic agents  |2 gnd 
655 7 |a biological therapy  |2 gnd 
655 7 |a cytokines  |2 gnd 
655 7 |a interleukin 1 receptor antagonist protein  |2 gnd 
655 7 |a therapeutics  |2 gnd 
655 7 |a Anti-Bacterial Agents  |2 gnd 
655 7 |a Enzyme Inhibitors  |2 gnd 
655 7 |a Interleukin 1 Receptor Antagonist Protein  |2 gnd 
655 7 |a Hydroxychloroquine  |2 gnd 
655 7 |a 4QWG6N8QKH  |2 gnd 
655 7 |a Azithromycin  |2 gnd 
655 7 |a 83905-01-5  |2 gnd 
655 7 |a C-Reactive Protein  |2 gnd 
655 7 |a 9007-41-4  |2 gnd 
689 0 0 |A f  |a Letter 
689 0 |5 DE-601 
689 1 0 |a antirheumatic agents 
689 1 1 |a biological therapy 
689 1 2 |a cytokines 
689 1 3 |a interleukin 1 receptor antagonist protein 
689 1 4 |a therapeutics 
689 1 |5 DE-601 
689 2 0 |a Anti-Bacterial Agents 
689 2 1 |a Enzyme Inhibitors 
689 2 2 |a Interleukin 1 Receptor Antagonist Protein 
689 2 3 |a Hydroxychloroquine 
689 2 4 |A r  |a 4QWG6N8QKH 
689 2 5 |a Azithromycin 
689 2 6 |A r  |a 83905-01-5 
689 2 7 |a C-Reactive Protein 
689 2 8 |A r  |a 9007-41-4 
689 2 |5 DE-601 
700 1 |a Baldolli, Aurelie 
700 1 |a Geffray, Loïk 
700 1 |a Verdon, Renaud 
700 1 |a Bergot, Emmanuel 
700 1 |a Martin-Silva, Nicolas 
700 1 |a Justet, Aurélien 
773 0 8 |i in  |t Annals of the rheumatic diseases  |g Vol. 79, No. 10 (2020), p. 1381-1382  |q 79:10<1381-1382  |w (DE-601)NLM000174114  |x 1468-2060 
856 4 1 |u http://dx.doi.org/10.1136/annrheumdis-2020-217706  |3 Volltext 
912 |a GBV_NLM 
951 |a AR 
952 |d 79  |j 2020  |e 10  |b 01  |c 09  |h 1381-1382